HOME MY ACCOUNTABOUT BHIVACLINICAL CALCULATORSCLINICAL STANDARDSHIV MEDICINE JOURNAL BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15 January 2021. Click here to read the full statement. BHIVA GUIDELINES ON THE USE OF VACCINES IN HIV-POSITIVE Introduction. These guidelines provide updated, GRADE-based recommendations on the use of vaccines in HIV-positive adults. Several factors have made the updating of HIV-specific vaccination guidelines important: effective antiretroviral therapy (ART) has substantially modified the natural history of HIV infection, vaccination practices are evolving, and a large number of novel vaccines are

CURRENT GUIDELINES

Current Guidelines. Each full guideline is presented below, in alphabetical order, with a short non-technical summary alongside the main guideline. The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with

your

2021 CONFERENCES AND EVENTS 2021 Conferences and Events. BHIVA holds two conferences each year; the Annual Conference of BHIVA is held in the spring, traditionally in April, and the BHIVA Autumn Conference is held in October. The Annual Conference venue rotates each year in order to try and give all members across the UK the greatest opportunity to attend on a regular

basis.

SARS-COV-2 VACCINE ADVICE FOR ADULTS LIVING WITH HIV This guidance was updated on 11 January 2021; click here to see the latest version Wednesday 9 December 2020. Introduction. The UK was the first country to approve the use of a SARS-CoV-2 vaccine, Pfizer’s BioNTech COVID-19 vaccine, to BHIVA GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN Introduction. The overall purpose of these guidelines is to help physicians manage adults with tuberculosis (TB)/human immunodeficiency virus (HIV) co-infection. BHIVA AND BIA GUIDELINES FOR THE TREATMENT OF Downloads. British HIV Association and British Infection Association Guidelines for the Treatment of Opportunistic Infection in HIV-seropositive Individuals 2011 BHIVA GUIDELINES FOR ANTIRETROVIRAL TREATMENT OF HIV-2SEE MORE ON

BHIVA.ORG

ANNUAL NATIONAL HIV MORTALITY REVIEW Annual National HIV Mortality Review. BHIVA and Public Health England are collaborating on an annual national review of mortality among people with HIV. This review has been designed based on a working model that has been running in London since 2013. Through this review, we aim to better understand causes of death and preventable mortality BHIVA GUIDELINES FOR THE ROUTINE INVESTIGATION AND BHIVA guidelines on the routine investigation and monitoring of HIV-1-positive adults 4 1. Introduction This guideline is an update of that produced in 2011 to reflect the HOME MY ACCOUNTABOUT BHIVACLINICAL CALCULATORSCLINICAL STANDARDSHIV MEDICINE JOURNAL BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15 January 2021. Click here to read the full statement. BHIVA GUIDELINES ON THE USE OF VACCINES IN HIV-POSITIVE Introduction. These guidelines provide updated, GRADE-based recommendations on the use of vaccines in HIV-positive adults. Several factors have made the updating of HIV-specific vaccination guidelines important: effective antiretroviral therapy (ART) has substantially modified the natural history of HIV infection, vaccination practices are evolving, and a large number of novel vaccines are

CURRENT GUIDELINES

Current Guidelines. Each full guideline is presented below, in alphabetical order, with a short non-technical summary alongside the main guideline. The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with

your

2021 CONFERENCES AND EVENTS 2021 Conferences and Events. BHIVA holds two conferences each year; the Annual Conference of BHIVA is held in the spring, traditionally in April, and the BHIVA Autumn Conference is held in October. The Annual Conference venue rotates each year in order to try and give all members across the UK the greatest opportunity to attend on a regular

basis.

SARS-COV-2 VACCINE ADVICE FOR ADULTS LIVING WITH HIV This guidance was updated on 11 January 2021; click here to see the latest version Wednesday 9 December 2020. Introduction. The UK was the first country to approve the use of a SARS-CoV-2 vaccine, Pfizer’s BioNTech COVID-19 vaccine, to BHIVA GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN Introduction. The overall purpose of these guidelines is to help physicians manage adults with tuberculosis (TB)/human immunodeficiency virus (HIV) co-infection. BHIVA AND BIA GUIDELINES FOR THE TREATMENT OF Downloads. British HIV Association and British Infection Association Guidelines for the Treatment of Opportunistic Infection in HIV-seropositive Individuals 2011 BHIVA GUIDELINES FOR ANTIRETROVIRAL TREATMENT OF HIV-2SEE MORE ON

BHIVA.ORG

ANNUAL NATIONAL HIV MORTALITY REVIEW Annual National HIV Mortality Review. BHIVA and Public Health England are collaborating on an annual national review of mortality among people with HIV. This review has been designed based on a working model that has been running in London since 2013. Through this review, we aim to better understand causes of death and preventable mortality BHIVA GUIDELINES FOR THE ROUTINE INVESTIGATION AND BHIVA guidelines on the routine investigation and monitoring of HIV-1-positive adults 4 1. Introduction This guideline is an update of that produced in 2011 to reflect the CORONAVIRUS (COVID-19) AND HIV COVID risk and vaccine updates. Wednesday 12 May 2021. BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15 January 2021. SARS-CoV-2

vaccine

BHIVA GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN Introduction. The overall purpose of these guidelines is to help physicians manage adults with tuberculosis (TB)/human immunodeficiency virus (HIV) co-infection. BHIVA GUIDELINES FOR THE MANAGEMENT OF HIV IN PREGNANCY Introduction. The overall purpose of these guidelines is to provide guidance on best clinical practice in the treatment and management of women living with HIV in the BHIVA/BASHH/BIA ADULT HIV TESTING GUIDELINES 2020 The elimination of human immunodeficiency virus (HIV) transmission in the UK is now considered to be an achievable ambition. To attain this target all individuals living with undiagnosed HIV will need to be offered testing and commenced on antiretroviral therapy (ART). The early initiation of ART, regardless of CD4 cell count, has clear

benefit

BHIVA GUIDELINES FOR THE TREATMENT OF HIV-1-POSITIVE Downloads. BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 (2016 interim update). BHIVA treatment guidelines: 2019 interim statement on two-drug regimens

EXECUTIVE COMMITTEE

Dr Mackie served as a trustee member of the BHIVA Executive Committee from 2016–2019 and was re-elected in 2019 for a further three-year term. She was elected in 2020 as chair of the Conferences Subcommittee for a three-year term. Mrs Sheila Morris. Mrs Sheila Morris works as BRITISH HIV ASSOCIATION STANDARDS OF CARE FOR PEOPLE The BHIVA Standards of Care were published in 2018. This is a valuable document, setting out the standards of care expected in the UK for people living with HIV. While the document is great for those delivering care, or commissioning care, the content can be quite challenging to understand for those receiving care – people living

with HIV.

BHIVA GUIDELINES FOR THE MANAGEMENT OF HEPATITIS VIRUSES Update - October 2015 Please note that the BHIVA guidelines for the management of hepatitis viruses in adults infected with HIV 2013 are

now out of date.

BHIVA GUIDELINES FOR HIV-ASSOCIATED MALIGNANCIES 2014 The overall purpose of these guidelines is to provide guidance on best clinical practice in the treatment and management of adults with HIV infection and malignancy. The scope includes the management of diagnosed malignancies in people living with HIV but does BHIVA GUIDELINES FOR THE ROUTINE INVESTIGATION AND BHIVA guidelines on the routine investigation and monitoring of HIV-1-positive adults 4 1. Introduction This guideline is an update of that produced in 2011 to reflect the HOME MY ACCOUNTABOUT BHIVACLINICAL CALCULATORSCLINICAL STANDARDSHIV MEDICINE JOURNAL BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15 January 2021. Click here to read the full statement.

CURRENT GUIDELINES

Current Guidelines. Each full guideline is presented below, in alphabetical order, with a short non-technical summary alongside the main guideline. The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with

your

BHIVA GUIDELINES ON THE USE OF VACCINES IN HIV-POSITIVE Introduction. These guidelines provide updated, GRADE-based recommendations on the use of vaccines in HIV-positive adults. Several factors have made the updating of HIV-specific vaccination guidelines important: effective antiretroviral therapy (ART) has substantially modified the natural history of HIV infection, vaccination practices are evolving, and a large number of novel vaccines are 2021 CONFERENCES AND EVENTS 2021 Conferences and Events. BHIVA holds two conferences each year; the Annual Conference of BHIVA is held in the spring, traditionally in April, and the BHIVA Autumn Conference is held in October. The Annual Conference venue rotates each year in order to try and give all members across the UK the greatest opportunity to attend on a regular

basis.

SARS-COV-2 VACCINE ADVICE FOR ADULTS LIVING WITH HIV This guidance was updated on 11 January 2021; click here to see the latest version Wednesday 9 December 2020. Introduction. The UK was the first country to approve the use of a SARS-CoV-2 vaccine, Pfizer’s BioNTech COVID-19 vaccine, to BHIVA AND BIA GUIDELINES FOR THE TREATMENT OF Downloads. British HIV Association and British Infection Association Guidelines for the Treatment of Opportunistic Infection in HIV-seropositive Individuals 2011 BHIVA GUIDELINES FOR THE MANAGEMENT OF HIV IN PREGNANCYSEE MORE ON

BHIVA.ORG

EXECUTIVE COMMITTEE

Dr Mackie served as a trustee member of the BHIVA Executive Committee from 2016–2019 and was re-elected in 2019 for a further three-year term. She was elected in 2020 as chair of the Conferences Subcommittee for a three-year term. Mrs Sheila Morris. Mrs Sheila Morris works as ANNUAL NATIONAL HIV MORTALITY REVIEW Annual National HIV Mortality Review. BHIVA and Public Health England are collaborating on an annual national review of mortality among people with HIV. This review has been designed based on a working model that has been running in London since 2013. Through this review, we aim to better understand causes of death and preventable mortality BRITISH HIV ASSOCIATION STANDARDS OF CARE FOR PEOPLE The BHIVA Standards of Care were published in 2018. This is a valuable document, setting out the standards of care expected in the UK for people living with HIV. While the document is great for those delivering care, or commissioning care, the content can be quite challenging to understand for those receiving care – people living

with HIV.

HOME MY ACCOUNTABOUT BHIVACLINICAL CALCULATORSCLINICAL STANDARDSHIV MEDICINE JOURNAL BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15 January 2021. Click here to read the full statement.

CURRENT GUIDELINES

Current Guidelines. Each full guideline is presented below, in alphabetical order, with a short non-technical summary alongside the main guideline. The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with

your

BHIVA GUIDELINES ON THE USE OF VACCINES IN HIV-POSITIVE Introduction. These guidelines provide updated, GRADE-based recommendations on the use of vaccines in HIV-positive adults. Several factors have made the updating of HIV-specific vaccination guidelines important: effective antiretroviral therapy (ART) has substantially modified the natural history of HIV infection, vaccination practices are evolving, and a large number of novel vaccines are 2021 CONFERENCES AND EVENTS 2021 Conferences and Events. BHIVA holds two conferences each year; the Annual Conference of BHIVA is held in the spring, traditionally in April, and the BHIVA Autumn Conference is held in October. The Annual Conference venue rotates each year in order to try and give all members across the UK the greatest opportunity to attend on a regular

basis.

SARS-COV-2 VACCINE ADVICE FOR ADULTS LIVING WITH HIV This guidance was updated on 11 January 2021; click here to see the latest version Wednesday 9 December 2020. Introduction. The UK was the first country to approve the use of a SARS-CoV-2 vaccine, Pfizer’s BioNTech COVID-19 vaccine, to BHIVA AND BIA GUIDELINES FOR THE TREATMENT OF Downloads. British HIV Association and British Infection Association Guidelines for the Treatment of Opportunistic Infection in HIV-seropositive Individuals 2011 BHIVA GUIDELINES FOR THE MANAGEMENT OF HIV IN PREGNANCYSEE MORE ON

BHIVA.ORG

EXECUTIVE COMMITTEE

Dr Mackie served as a trustee member of the BHIVA Executive Committee from 2016–2019 and was re-elected in 2019 for a further three-year term. She was elected in 2020 as chair of the Conferences Subcommittee for a three-year term. Mrs Sheila Morris. Mrs Sheila Morris works as ANNUAL NATIONAL HIV MORTALITY REVIEW Annual National HIV Mortality Review. BHIVA and Public Health England are collaborating on an annual national review of mortality among people with HIV. This review has been designed based on a working model that has been running in London since 2013. Through this review, we aim to better understand causes of death and preventable mortality BRITISH HIV ASSOCIATION STANDARDS OF CARE FOR PEOPLE The BHIVA Standards of Care were published in 2018. This is a valuable document, setting out the standards of care expected in the UK for people living with HIV. While the document is great for those delivering care, or commissioning care, the content can be quite challenging to understand for those receiving care – people living

with HIV.

CORONAVIRUS (COVID-19) AND HIV COVID risk and vaccine updates. Wednesday 12 May 2021. BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15 January 2021. SARS-CoV-2

vaccine

SARS-COV-2 VACCINE ADVICE FOR ADULTS LIVING WITH HIV This guidance was updated on 11 January 2021; click here to see the latest version Wednesday 9 December 2020. Introduction. The UK was the first country to approve the use of a SARS-CoV-2 vaccine, Pfizer’s BioNTech COVID-19 vaccine, to

EXECUTIVE COMMITTEE

Dr Mackie served as a trustee member of the BHIVA Executive Committee from 2016–2019 and was re-elected in 2019 for a further three-year term. She was elected in 2020 as chair of the Conferences Subcommittee for a three-year term. Mrs Sheila Morris. Mrs Sheila Morris works as BHIVA GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN Introduction. The overall purpose of these guidelines is to help physicians manage adults with tuberculosis (TB)/human immunodeficiency virus (HIV) co-infection. BHIVA/BASHH/BIA ADULT HIV TESTING GUIDELINES 2020 The elimination of human immunodeficiency virus (HIV) transmission in the UK is now considered to be an achievable ambition. To attain this target all individuals living with undiagnosed HIV will need to be offered testing and commenced on antiretroviral therapy (ART). The early initiation of ART, regardless of CD4 cell count, has clear

benefit

BHIVA GUIDELINES FOR HIV-ASSOCIATED MALIGNANCIES 2014 The overall purpose of these guidelines is to provide guidance on best clinical practice in the treatment and management of adults with HIV infection and malignancy. The scope includes the management of diagnosed malignancies in people living with HIV but does BHIVA GUIDELINES FOR THE MANAGEMENT OF HEPATITIS VIRUSES Update - October 2015 Please note that the BHIVA guidelines for the management of hepatitis viruses in adults infected with HIV 2013 are

now out of date.

12.0 MANAGEMENT OF RELAPSE, TREATMENT FAILURE AND DRUG One of the fundamental principles in managing patients with treatment failure is never to add a single drug to a failing regimen, as this leads to acquired resistance to the new drug. Instead, at least two, and preferably three, new drugs to which the patient has not been exposed and susceptibility thought likely should be added. BHIVA GUIDELINES FOR THE ROUTINE INVESTIGATION AND BHIVA guidelines on the routine investigation and monitoring of HIV-1-positive adults 4 1. Introduction This guideline is an update of that produced in 2011 to reflect the HIV AND BREASTFEEDING YOUR BABY HIV and breastfeeding your baby The safest way for a mother living with HIV in the UK to feed her baby is to bottle feed using formula milk. If you are on treatment with an undetectable viral load and choose to breastfeed your baby we can HOME MY ACCOUNTABOUT BHIVACLINICAL CALCULATORSCLINICAL STANDARDSHIV MEDICINE JOURNAL BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15 January 2021. Click here to read the full statement.

CURRENT GUIDELINES

Current Guidelines. Each full guideline is presented below, in alphabetical order, with a short non-technical summary alongside the main guideline. The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with

your

BHIVA GUIDELINES ON THE USE OF VACCINES IN HIV-POSITIVE Introduction. These guidelines provide updated, GRADE-based recommendations on the use of vaccines in HIV-positive adults. Several factors have made the updating of HIV-specific vaccination guidelines important: effective antiretroviral therapy (ART) has substantially modified the natural history of HIV infection, vaccination practices are evolving, and a large number of novel vaccines are 2021 CONFERENCES AND EVENTS 2021 Conferences and Events. BHIVA holds two conferences each year; the Annual Conference of BHIVA is held in the spring, traditionally in April, and the BHIVA Autumn Conference is held in October. The Annual Conference venue rotates each year in order to try and give all members across the UK the greatest opportunity to attend on a regular

basis.

SARS-COV-2 VACCINE ADVICE FOR ADULTS LIVING WITH HIV This guidance was updated on 11 January 2021; click here to see the latest version Wednesday 9 December 2020. Introduction. The UK was the first country to approve the use of a SARS-CoV-2 vaccine, Pfizer’s BioNTech COVID-19 vaccine, to BHIVA AND BIA GUIDELINES FOR THE TREATMENT OF Downloads. British HIV Association and British Infection Association Guidelines for the Treatment of Opportunistic Infection in HIV-seropositive Individuals 2011 BHIVA GUIDELINES FOR THE MANAGEMENT OF HIV IN PREGNANCYSEE MORE ON

BHIVA.ORG

EXECUTIVE COMMITTEE

Dr Mackie served as a trustee member of the BHIVA Executive Committee from 2016–2019 and was re-elected in 2019 for a further three-year term. She was elected in 2020 as chair of the Conferences Subcommittee for a three-year term. Mrs Sheila Morris. Mrs Sheila Morris works as ANNUAL NATIONAL HIV MORTALITY REVIEW Annual National HIV Mortality Review. BHIVA and Public Health England are collaborating on an annual national review of mortality among people with HIV. This review has been designed based on a working model that has been running in London since 2013. Through this review, we aim to better understand causes of death and preventable mortality BRITISH HIV ASSOCIATION STANDARDS OF CARE FOR PEOPLE The BHIVA Standards of Care were published in 2018. This is a valuable document, setting out the standards of care expected in the UK for people living with HIV. While the document is great for those delivering care, or commissioning care, the content can be quite challenging to understand for those receiving care – people living

with HIV.

HOME MY ACCOUNTABOUT BHIVACLINICAL CALCULATORSCLINICAL STANDARDSHIV MEDICINE JOURNAL BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15 January 2021. Click here to read the full statement.

CURRENT GUIDELINES

Current Guidelines. Each full guideline is presented below, in alphabetical order, with a short non-technical summary alongside the main guideline. The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with

your

BHIVA GUIDELINES ON THE USE OF VACCINES IN HIV-POSITIVE Introduction. These guidelines provide updated, GRADE-based recommendations on the use of vaccines in HIV-positive adults. Several factors have made the updating of HIV-specific vaccination guidelines important: effective antiretroviral therapy (ART) has substantially modified the natural history of HIV infection, vaccination practices are evolving, and a large number of novel vaccines are 2021 CONFERENCES AND EVENTS 2021 Conferences and Events. BHIVA holds two conferences each year; the Annual Conference of BHIVA is held in the spring, traditionally in April, and the BHIVA Autumn Conference is held in October. The Annual Conference venue rotates each year in order to try and give all members across the UK the greatest opportunity to attend on a regular

basis.

SARS-COV-2 VACCINE ADVICE FOR ADULTS LIVING WITH HIV This guidance was updated on 11 January 2021; click here to see the latest version Wednesday 9 December 2020. Introduction. The UK was the first country to approve the use of a SARS-CoV-2 vaccine, Pfizer’s BioNTech COVID-19 vaccine, to BHIVA AND BIA GUIDELINES FOR THE TREATMENT OF Downloads. British HIV Association and British Infection Association Guidelines for the Treatment of Opportunistic Infection in HIV-seropositive Individuals 2011 BHIVA GUIDELINES FOR THE MANAGEMENT OF HIV IN PREGNANCYSEE MORE ON

BHIVA.ORG

EXECUTIVE COMMITTEE

Dr Mackie served as a trustee member of the BHIVA Executive Committee from 2016–2019 and was re-elected in 2019 for a further three-year term. She was elected in 2020 as chair of the Conferences Subcommittee for a three-year term. Mrs Sheila Morris. Mrs Sheila Morris works as ANNUAL NATIONAL HIV MORTALITY REVIEW Annual National HIV Mortality Review. BHIVA and Public Health England are collaborating on an annual national review of mortality among people with HIV. This review has been designed based on a working model that has been running in London since 2013. Through this review, we aim to better understand causes of death and preventable mortality BRITISH HIV ASSOCIATION STANDARDS OF CARE FOR PEOPLE The BHIVA Standards of Care were published in 2018. This is a valuable document, setting out the standards of care expected in the UK for people living with HIV. While the document is great for those delivering care, or commissioning care, the content can be quite challenging to understand for those receiving care – people living

with HIV.

CORONAVIRUS (COVID-19) AND HIV COVID risk and vaccine updates. Wednesday 12 May 2021. BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15 January 2021. SARS-CoV-2

vaccine

SARS-COV-2 VACCINE ADVICE FOR ADULTS LIVING WITH HIV This guidance was updated on 11 January 2021; click here to see the latest version Wednesday 9 December 2020. Introduction. The UK was the first country to approve the use of a SARS-CoV-2 vaccine, Pfizer’s BioNTech COVID-19 vaccine, to

EXECUTIVE COMMITTEE

Dr Mackie served as a trustee member of the BHIVA Executive Committee from 2016–2019 and was re-elected in 2019 for a further three-year term. She was elected in 2020 as chair of the Conferences Subcommittee for a three-year term. Mrs Sheila Morris. Mrs Sheila Morris works as BHIVA GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN Introduction. The overall purpose of these guidelines is to help physicians manage adults with tuberculosis (TB)/human immunodeficiency virus (HIV) co-infection. BHIVA/BASHH/BIA ADULT HIV TESTING GUIDELINES 2020 The elimination of human immunodeficiency virus (HIV) transmission in the UK is now considered to be an achievable ambition. To attain this target all individuals living with undiagnosed HIV will need to be offered testing and commenced on antiretroviral therapy (ART). The early initiation of ART, regardless of CD4 cell count, has clear

benefit

BHIVA GUIDELINES FOR HIV-ASSOCIATED MALIGNANCIES 2014 The overall purpose of these guidelines is to provide guidance on best clinical practice in the treatment and management of adults with HIV infection and malignancy. The scope includes the management of diagnosed malignancies in people living with HIV but does BHIVA GUIDELINES FOR THE MANAGEMENT OF HEPATITIS VIRUSES Update - October 2015 Please note that the BHIVA guidelines for the management of hepatitis viruses in adults infected with HIV 2013 are

now out of date.

12.0 MANAGEMENT OF RELAPSE, TREATMENT FAILURE AND DRUG One of the fundamental principles in managing patients with treatment failure is never to add a single drug to a failing regimen, as this leads to acquired resistance to the new drug. Instead, at least two, and preferably three, new drugs to which the patient has not been exposed and susceptibility thought likely should be added. BHIVA GUIDELINES FOR THE ROUTINE INVESTIGATION AND BHIVA guidelines on the routine investigation and monitoring of HIV-1-positive adults 4 1. Introduction This guideline is an update of that produced in 2011 to reflect the HIV AND BREASTFEEDING YOUR BABY HIV and breastfeeding your baby The safest way for a mother living with HIV in the UK to feed her baby is to bottle feed using formula milk. If you are on treatment with an undetectable viral load and choose to breastfeed your baby we can HOME MY ACCOUNTABOUT BHIVACLINICAL CALCULATORSCLINICAL STANDARDSHIV MEDICINE JOURNALBRITISH HIV ASSOCIATION GUIDELINESHIV 101 TRAININGNATIONAL GUIDELINES HIV BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15

January 2021.

CURRENT GUIDELINES

Current Guidelines. Each full guideline is presented below, in alphabetical order, with a short non-technical summary alongside the main guideline. The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with

your

BHIVA GUIDELINES ON THE USE OF VACCINES IN HIV-POSITIVE Introduction. These guidelines provide updated, GRADE-based recommendations on the use of vaccines in HIV-positive adults. Several factors have made the updating of HIV-specific vaccination guidelines important: effective antiretroviral therapy (ART) has substantially modified the natural history of HIV infection, vaccination practices are evolving, and a large number of novel vaccines are CORONAVIRUS (COVID-19) AND HIV COVID risk and vaccine updates. Wednesday 12 May 2021. BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15 January 2021. SARS-CoV-2

vaccine

2021 CONFERENCES AND EVENTS 2021 Conferences and Events. BHIVA holds two conferences each year; the Annual Conference of BHIVA is held in the spring, traditionally in April, and the BHIVA Autumn Conference is held in October. The Annual Conference venue rotates each year in order to try and give all members across the UK the greatest opportunity to attend on a regular

basis.

BHIVA AND BIA GUIDELINES FOR THE TREATMENT OFIDSA OPPORTUNISTIC INFECTION GUIDELINESCDC HIV GUIDELINESHIV AIDS GUIDELINESHIV GUIDELINES 2019WHEN TO START OI PROPHYLAXIS IN HIV Downloads. British HIV Association and British Infection Association Guidelines for the Treatment of Opportunistic Infection in HIV-seropositive Individuals 2011

EXECUTIVE COMMITTEE

Dr Mackie served as a trustee member of the BHIVA Executive Committee from 2016–2019 and was re-elected in 2019 for a further three-year term. She was elected in 2020 as chair of the Conferences Subcommittee for a three-year term. Mrs Sheila Morris. Mrs Sheila Morris works as ANNUAL NATIONAL HIV MORTALITY REVIEW Annual National HIV Mortality Review. BHIVA and Public Health England are collaborating on an annual national review of mortality among people with HIV. This review has been designed based on a working model that has been running in London since 2013. Through this review, we aim to better understand causes of death and preventable mortality BRITISH HIV ASSOCIATION STANDARDS OF CARE FOR PEOPLEHRSA STANDARDS OF CARE HIVSTANDARDS OF CARE IN HEALTH CARE2017 HIV AIDS STATISTICSHIV AIDS PREVALENCE WORLDWIDEHIV CDC GUIDELINESHIV GUIDELINES 2019 The BHIVA Standards of Care were published in 2018. This is a valuable document, setting out the standards of care expected in the UK for people living with HIV. While the document is great for those delivering care, or commissioning care, the content can be quite challenging to understand for those receiving care – people living

with HIV.

HIV AND BREASTFEEDING YOUR BABYHIV AND BREASTFEEDING GUIDELINE 2013HIV AND BREASTFEEDING RECOMMENDATIONSHIV BREASTFEEDING CDCHIV BREASTFEEDING GUIDELINESAAP BREASTFEEDING GUIDELINESBREASTFEEDING

GUIDELINES CDC

HIV and breastfeeding your baby The safest way for a mother living with HIV in the UK to feed her baby is to bottle feed using formula milk. If you are on treatment with an undetectable viral load and choose to breastfeed your baby we can HOME MY ACCOUNTABOUT BHIVACLINICAL CALCULATORSCLINICAL STANDARDSHIV MEDICINE JOURNALBRITISH HIV ASSOCIATION GUIDELINESHIV 101 TRAININGNATIONAL GUIDELINES HIV BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15

January 2021.

CURRENT GUIDELINES

Current Guidelines. Each full guideline is presented below, in alphabetical order, with a short non-technical summary alongside the main guideline. The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with

your

BHIVA GUIDELINES ON THE USE OF VACCINES IN HIV-POSITIVE Introduction. These guidelines provide updated, GRADE-based recommendations on the use of vaccines in HIV-positive adults. Several factors have made the updating of HIV-specific vaccination guidelines important: effective antiretroviral therapy (ART) has substantially modified the natural history of HIV infection, vaccination practices are evolving, and a large number of novel vaccines are CORONAVIRUS (COVID-19) AND HIV COVID risk and vaccine updates. Wednesday 12 May 2021. BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV. Friday 15 January 2021. SARS-CoV-2

vaccine

2021 CONFERENCES AND EVENTS 2021 Conferences and Events. BHIVA holds two conferences each year; the Annual Conference of BHIVA is held in the spring, traditionally in April, and the BHIVA Autumn Conference is held in October. The Annual Conference venue rotates each year in order to try and give all members across the UK the greatest opportunity to attend on a regular

basis.

BHIVA AND BIA GUIDELINES FOR THE TREATMENT OFIDSA OPPORTUNISTIC INFECTION GUIDELINESCDC HIV GUIDELINESHIV AIDS GUIDELINESHIV GUIDELINES 2019WHEN TO START OI PROPHYLAXIS IN HIV Downloads. British HIV Association and British Infection Association Guidelines for the Treatment of Opportunistic Infection in HIV-seropositive Individuals 2011

EXECUTIVE COMMITTEE

Dr Mackie served as a trustee member of the BHIVA Executive Committee from 2016–2019 and was re-elected in 2019 for a further three-year term. She was elected in 2020 as chair of the Conferences Subcommittee for a three-year term. Mrs Sheila Morris. Mrs Sheila Morris works as ANNUAL NATIONAL HIV MORTALITY REVIEW Annual National HIV Mortality Review. BHIVA and Public Health England are collaborating on an annual national review of mortality among people with HIV. This review has been designed based on a working model that has been running in London since 2013. Through this review, we aim to better understand causes of death and preventable mortality BRITISH HIV ASSOCIATION STANDARDS OF CARE FOR PEOPLEHRSA STANDARDS OF CARE HIVSTANDARDS OF CARE IN HEALTH CARE2017 HIV AIDS STATISTICSHIV AIDS PREVALENCE WORLDWIDEHIV CDC GUIDELINESHIV GUIDELINES 2019 The BHIVA Standards of Care were published in 2018. This is a valuable document, setting out the standards of care expected in the UK for people living with HIV. While the document is great for those delivering care, or commissioning care, the content can be quite challenging to understand for those receiving care – people living

with HIV.

HIV AND BREASTFEEDING YOUR BABYHIV AND BREASTFEEDING GUIDELINE 2013HIV AND BREASTFEEDING RECOMMENDATIONSHIV BREASTFEEDING CDCHIV BREASTFEEDING GUIDELINESAAP BREASTFEEDING GUIDELINESBREASTFEEDING

GUIDELINES CDC

HIV and breastfeeding your baby The safest way for a mother living with HIV in the UK to feed her baby is to bottle feed using formula milk. If you are on treatment with an undetectable viral load and choose to breastfeed your baby we can CORONAVIRUS (COVID-19) AND HIV COVID risk and vaccine updates Wednesday 12 May 2021. BHIVA, DAIG, EACS, GESIDA, Polish Scientific AIDS Society and Portuguese Association for the clinical study of AIDS (APECS) Statement on risk of COVID-19 for people living with HIV (PLWH) and SARS-CoV-2 vaccine advice for adults living with HIV BHIVA/BASHH/BIA ADULT HIV TESTING GUIDELINES 2020 The elimination of human immunodeficiency virus (HIV) transmission in the UK is now considered to be an achievable ambition. To attain this target all individuals living with undiagnosed HIV will need to be offered testing and commenced on antiretroviral therapy (ART). The early initiation of ART, regardless of CD4 cell count, has clear

benefit

BHIVA GUIDELINES FOR THE MANAGEMENT OF TUBERCULOSIS IN Introduction. The overall purpose of these guidelines is to help physicians manage adults with tuberculosis (TB)/human immunodeficiency virus (HIV) co-infection. BHIVA GUIDELINES FOR THE MANAGEMENT OF HIV IN PREGNANCY Introduction. The overall purpose of these guidelines is to provide guidance on best clinical practice in the treatment and management of women living with HIV in the BRITISH HIV ASSOCIATION STANDARDS OF CARE FOR PEOPLE The BHIVA Standards of Care were published in 2018. This is a valuable document, setting out the standards of care expected in the UK for people living with HIV. While the document is great for those delivering care, or commissioning care, the content can be quite challenging to understand for those receiving care – people living

with HIV.

BHIVA GUIDELINES FOR THE MANAGEMENT OF HEPATITIS VIRUSES Update - October 2015 Please note that the BHIVA guidelines for the management of hepatitis viruses in adults infected with HIV 2013 are

now out of date.

BHIVA GUIDELINES FOR HIV-ASSOCIATED MALIGNANCIES 2014 The overall purpose of these guidelines is to provide guidance on best clinical practice in the treatment and management of adults with HIV infection and malignancy. The scope includes the management of diagnosed malignancies in people living with HIV but does BHIVA GUIDELINES FOR THE TREATMENT OF HIV-1-POSITIVE The overall purpose of these guidelines was to provide guidance on best clinical practice in the treatment and management of adults with HIV infection on antiretroviral therapy (ART). The scope included: (i) guidance on the initiation of ART in those previously naïve to therapy; (ii) support of people living with HIV (PLWH) on treatment;

(iii

HIV AND BREASTFEEDING YOUR BABY HIV and breastfeeding your baby The safest way for a mother living with HIV in the UK to feed her baby is to bottle feed using formula milk. If you are on treatment with an undetectable viral load and choose to breastfeed your baby we can 12.0 MANAGEMENT OF RELAPSE, TREATMENT FAILURE AND DRUG One of the fundamental principles in managing patients with treatment failure is never to add a single drug to a failing regimen, as this leads to acquired resistance to the new drug. Instead, at least two, and preferably three, new drugs to which the patient has not been exposed and susceptibility thought likely should be added.

* My Account

* About BHIVA

* About us

* Committees

* Governance

* Membership

* Annual Report and Accounts

* BHIVA Patrons

* Media Requests

* Audits

* Introduction

* National Audit Reports * National Audit Schedule * Clinical Calculators * Clinical Guidelines

* Introduction

* Current Guidelines * Archived Guidelines

* Smartphone App

* Position Statements * Clinical Standards * Conferences & Events

* Introduction

* Forthcoming Events

* Previous Events

* 2020

* 2019

* 2018

* 2017

* 2016

* 2015

* Conference Abstracts

* HIV Event Diary

* Education & Research

* Introduction

* Diploma in HIV Medicine

* E-Learning

* Mentoring

* Research Awards

* BHIVA Research Awards * Gilead / BHIVA Research Award * HIV Medicine journal * International Partnerships * Latest BHIVA HIV and Coronavirus (COVID-19) advice

* News and Media

* Resources

* Patient specific information * Policy and Consultation Papers * Position Statements * Other publications

* Useful links

* Clinical Practice

* Educational

* Governmental

* HIV Services in the UK

* NGOs (Community)

* Professional Associations * Public Health and International

* Research

* Scholarships & Awards

* Introduction

* Conference Awards

* BHIVA Scholarships * BHIVA Research Awards

__ All Site

* Home

* Contact Us

* Login

* Join BHIVA

*

__

all

* My Account

* About BHIVA

* Audits

* Clinical Calculators * Clinical Guidelines * Clinical Standards * Conferences & Events * Education & Research * HIV Medicine journal * International Partnerships * Latest BHIVA HIV and Coronavirus (COVID-19) advice

* News and Media

* Resources

* Scholarships & Awards

* Home

* Contact Us

* Login

* Join BHIVA

* About us

* Committees

* Governance

* Membership

* Annual Report and Accounts

* BHIVA Patrons

* Media Requests

* Introduction

* National Audit Reports * National Audit Schedule

* Introduction

* Current Guidelines * Archived Guidelines

* Smartphone App

* Position Statements

* Introduction

* Forthcoming Events

* Previous Events

* Conference Abstracts

* HIV Event Diary

* 2020

* 2019

* 2018

* 2017

* 2016

* 2015

* Introduction

* Diploma in HIV Medicine

* E-Learning

* Mentoring

* Research Awards

* BHIVA Research Awards * Gilead / BHIVA Research Award * Patient specific information * Policy and Consultation Papers * Position Statements * Other publications

* Useful links

* Clinical Practice

* Educational

* Governmental

* HIV Services in the UK

* NGOs (Community)

* Professional Associations * Public Health and International

* Research

* Introduction

* Conference Awards

* BHIVA Scholarships * BHIVA Research Awards -------------------------

*

Previous

Next

BHIVA

MEDICAL

CLINICAL GUIDELINES

We produce a number of guidelines for the management of HIV.

BHIVA

MEDICAL

CONFERENCES AND EVENTS A number of conferences and events are arranged throughout the year.

BHIVA

MEDICAL

NEWS & STATEMENTS

View the latest news releases and statements from BHIVA.

BHIVA

MEDICAL

BHIVA SCHOLARSHIPS

BHIVA awards a number of scholarships throughout each year.

BHIVA

MEDICAL

HIV MEDICINE JOURNAL HIV Medicine covers all aspects of HIV treatment and diagnosis.

BHIVA

MEDICAL

CONTACT BHIVA SPOKESPEOPLE A number of HIV medical experts are available for media comment.

WHAT'S NEW

Postponement of BHIVA national audit 2020 26th Annual Conference of BHIVA (Manchester 2020) - Event Cancelled BHIVA 'Best of CROI' Feedback Meetings (2020) - Event Cancelled New E-Learning Module based on BHIVA guidelines for the management of HIV in pregnancy and postpartum BHIVA/Gilead International Exchange Fellowship Awards 2020 - Second

round now open

LATEST BHIVA STATEMENTS EACS & BHIVA Statement on risk of COVID-19 for people living with HIV

(PLWH)

British HIV Association (BHIVA) statement on considerations for critical care for people with HIV during COVID-19 BHIVA statement on management of a pregnant woman living with HIV and infant testing during Coronavirus (COVID-19) British HIV Association (BHIVA) and Terrence Higgins Trust (THT) statement on COVID-19 and advice for the extremely vulnerable Comment from BHIVA and THT on UK Government Guidance on Coronavirus (COVID-19), Social Distancing to Protect Vulnerable Adults and Shielding to Protect Extremely Vulnerable Adults (_published 23 March

2020_)

Joint statement on risk of Coronavirus (COVID-19) for people living with HIV (PLWH) - European AIDS Clinical Society (EACS) and British HIV Association (BHIVA) Coronavirus (COVID-19) and HIV - Responses to common questions from the British HIV Association (BHIVA)

View all

×

BHIVA LOGIN

Login

* Disclaimer

* BHIVA refund and cancellation policy

* Privacy

* Sitemap

DOWNLOAD BHIVA APPS

`

© Copyright British HIV Association (BHIVA) 2020 Registered Charity Number 1170707

__ __

__